Old Logo.png
Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development
18 mars 2021 08h30 HE | Cancer Genetics, Inc.
RUTHERFORD, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today the appointment of...
Old Logo.png
Cancer Genetics to Present at the Annual 33rd ROTH Conference
12 mars 2021 09h30 HE | Cancer Genetics, Inc.
RUTHERFORD, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts,...
Old Logo.png
Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright
07 janv. 2021 16h05 HE | Cancer Genetics, Inc.
RUTHERFORD, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts,...
Joint Logo.png
Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program
03 sept. 2020 08h00 HE | Cancer Genetics, Inc.
RUTHERFORD, N.J., and MAPLE GROVE, MN, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, and...
33729.jpg
Cancer Genetics and StemoniX Sign Definitive Agreement to Merge
24 août 2020 08h00 HE | Cancer Genetics, Inc.
Combined Company Positioned to Offer Best-in-Class and Innovative Drug Discovery Solutions RUTHERFORD, NJ and MAPLE GROVE, MN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the...